[GAMUDA] QoQ Cumulative Quarter Result on 31-Oct-2019 [#1]

Stock
[GAMUDA] GAMUDA BHD
Announcement Date
13-Dec-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Jul-2020
Quarter
31-Oct-2019 [#1]
Profit Trend
QoQ- -75.41%
YoY- 0.92%
Quarter Report
Latest QR
Upcoming QR
GAMUDA's Result
GAMUDA's Financial Summary
View:
Show?
Cumulative Result
31/07/20 30/04/20 31/01/20 31/10/19 31/07/19 30/04/19 31/01/19 CAGR
Revenue 3,662,964 2,736,447 2,186,543 1,095,829 4,565,062 3,065,692 2,029,010 48.31%
PBT 585,462 502,759 437,670 217,965 908,849 685,164 449,608 19.26%
Tax -161,272 -83,859 -66,184 -32,374 -150,654 -119,598 -73,864 68.38%
NP 424,190 418,900 371,486 185,591 758,195 565,566 375,744 8.42%
-
NP to SH 371,680 389,020 348,788 173,615 706,113 521,165 345,178 5.05%
-
Tax Rate 27.55% 16.68% 15.12% 14.85% 16.58% 17.46% 16.43% -
Total Cost 3,238,774 2,317,547 1,815,057 910,238 3,806,867 2,500,126 1,653,266 56.62%
-
Net Worth 8,545,994 8,595,168 8,273,487 8,284,814 8,052,542 8,021,825 7,823,715 6.06%
Dividend
31/07/20 30/04/20 31/01/20 31/10/19 31/07/19 30/04/19 31/01/19 CAGR
Div 150,811 150,792 148,625 148,384 296,412 296,190 148,082 1.22%
Div Payout % 40.58% 38.76% 42.61% 85.47% 41.98% 56.83% 42.90% -
Equity
31/07/20 30/04/20 31/01/20 31/10/19 31/07/19 30/04/19 31/01/19 CAGR
Net Worth 8,545,994 8,595,168 8,273,487 8,284,814 8,052,542 8,021,825 7,823,715 6.06%
NOSH 2,513,527 2,513,527 2,481,507 2,473,407 2,472,322 2,468,497 2,468,050 1.22%
Ratio Analysis
31/07/20 30/04/20 31/01/20 31/10/19 31/07/19 30/04/19 31/01/19 CAGR
NP Margin 11.58% 15.31% 16.99% 16.94% 16.61% 18.45% 18.52% -
ROE 4.35% 4.53% 4.22% 2.10% 8.77% 6.50% 4.41% -
Per Share
31/07/20 30/04/20 31/01/20 31/10/19 31/07/19 30/04/19 31/01/19 CAGR
RPS 145.73 108.88 88.27 44.31 184.81 124.20 82.21 46.52%
EPS 14.94 15.64 14.09 7.02 28.60 21.12 13.99 4.48%
DPS 6.00 6.00 6.00 6.00 12.00 12.00 6.00 0.00%
NAPS 3.40 3.42 3.34 3.35 3.26 3.25 3.17 4.78%
Adjusted Per Share Value based on latest NOSH - 2,473,407
31/07/20 30/04/20 31/01/20 31/10/19 31/07/19 30/04/19 31/01/19 CAGR
RPS 129.82 96.98 77.49 38.84 161.79 108.65 71.91 48.31%
EPS 13.17 13.79 12.36 6.15 25.02 18.47 12.23 5.06%
DPS 5.34 5.34 5.27 5.26 10.50 10.50 5.25 1.14%
NAPS 3.0287 3.0461 2.9321 2.9361 2.8538 2.8429 2.7727 6.06%
Price Multiplier on Financial Quarter End Date
31/07/20 30/04/20 31/01/20 31/10/19 31/07/19 30/04/19 31/01/19 CAGR
Date 30/07/20 30/04/20 31/01/20 31/10/19 31/07/19 30/04/19 31/01/19 -
Price 3.56 3.22 3.86 3.74 3.71 3.50 2.76 -
P/RPS 2.44 2.96 4.37 8.44 2.01 2.82 3.36 -19.22%
P/EPS 24.07 20.80 27.41 53.27 12.98 16.58 19.73 14.18%
EY 4.15 4.81 3.65 1.88 7.71 6.03 5.07 -12.50%
DY 1.69 1.86 1.55 1.60 3.23 3.43 2.17 -15.36%
P/NAPS 1.05 0.94 1.16 1.12 1.14 1.08 0.87 13.36%
Price Multiplier on Announcement Date
31/07/20 30/04/20 31/01/20 31/10/19 31/07/19 30/04/19 31/01/19 CAGR
Date 25/09/20 24/06/20 25/03/20 13/12/19 27/09/19 27/06/19 27/03/19 -
Price 3.25 3.53 2.65 3.78 3.56 3.72 2.80 -
P/RPS 2.23 3.24 3.00 8.53 1.93 3.00 3.41 -24.67%
P/EPS 21.98 22.81 18.82 53.84 12.45 17.62 20.02 6.43%
EY 4.55 4.38 5.31 1.86 8.03 5.68 4.99 -5.97%
DY 1.85 1.70 2.26 1.59 3.37 3.23 2.14 -9.25%
P/NAPS 0.96 1.03 0.79 1.13 1.09 1.14 0.88 5.97%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment